<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
43742-2571-1
</NDCCode>
<PackageDescription>
3840 mL in 1 CONTAINER (43742-2571-1)
</PackageDescription>
<NDC11Code>
43742-2571-01
</NDC11Code>
<ProductNDC>
43742-2571
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Coxsackie A2, A7, B1, B3, B4, B5 Nosodes
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20261029
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Deseret Biologicals
</LabelerName>
<SubstanceName>
HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B4; HUMAN COXSACKIEVIRUS B5
</SubstanceName>
<StrengthNumber>
1; 1; 1; 1; 1; 1
</StrengthNumber>
<StrengthUnit>
[hp_M]/mL; [hp_M]/mL; [hp_M]/mL; [hp_M]/mL; [hp_M]/mL; [hp_M]/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-10-31
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
29-OCT-26
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>